Joseph Dennis

Joseph Dennis is a Senior Scientist at Iambic Therapeutics since September 2021, where previously the role of Scientist II was held. Prior experience includes serving as a Research Scientist at Vertex Pharmaceuticals from March 2020 to September 2021 and being an NSF Predoctoral Fellow at the Massachusetts Institute of Technology from August 2015 to January 2020, under the guidance of Stephen Buchwald. An internship in Pivotal Drug Substance Technologies was completed at Amgen from January 2019 to June 2019. Joseph Dennis holds a Doctor of Philosophy (PhD) in Chemistry from the Massachusetts Institute of Technology, obtained in 2020, and a Bachelor of Science (BS) in Chemistry from Hope College, earned in 2015.